Literature DB >> 20149290

Genetic diversity of Plasmodium falciparum in Bolifamba, on the slopes of Mount Cameroon: influence of MSP1 allelic variants on symptomatic malaria and anaemia.

D N Anong1, T Nkuo-Akenji, J Fru-Cho, A Amambua-Ngwa, V P K Titanji.   

Abstract

The influence of the genetic diversity of Plasmodium falciparum infection on the clinical presentation of human malaria was investigated in rural Bolifamba, Cameroon. Parasite DNA was obtained from the blood of 208 children (aged 1-15 years) with malarial infection. The prevalences of anaemia and symptomatic and asymptomatic malaria among these children were 57.7%, 51.4% and 48.6%, respectively. The frequencies of parasites carrying each of the block-2 allelic variants (MAD20, K1 and RO33) of merozoite surface protein 1 (MSP1) were compared among the symptomatic and asymptomatic cases of malaria, the anaemic and non-anaemic subjects, and in various age groupings. Although all three allelic variants were found in Bolifamba, 32.7% of the children investigated were co-infected with parasites carrying the RO33 and K1 variants. There was a significant difference in the prevalence of each MSP1 allelic variant both between age-groups and between the various categories of anaemia considered (P<0.0001 for each), with the highest number of alleles occurring in the children with severe anaemia. The combination of RO33/K1 co-infection and anaemia was detected in most (57.7%) of the children aged 3-<6 years. The RO33/K1 co-infection was also strongly associated with both fever and high levels of parasitaemia (P<0.0001 for each). Although the children of Bolifamba are exposed to all three allelic variants of MSP1, which occur either singly or in varying combinations in the infected children, RO33/K1 co-infections are particularly associated with fever and this association appears independent of age and parasite density. The preliminary data presented here should facilitate the design of future research towards the development and testing of malaria candidate vaccines in the study area.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20149290     DOI: 10.1179/136485910X12607012373876

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  10 in total

1.  Plasmodium falciparum msp1 and msp2 genetic diversity in parasites isolated from symptomatic and asymptomatic malaria subjects in the South of Benin.

Authors:  Hamirath Odée Lagnika; Azizath Moussiliou; Romuald Agonhossou; Pierre Sovegnon; Oswald Yédjinnavênan Djihinto; Adandé Assogba Medjigbodo; Laurette Djossou; Linda Eva Amoah; Aurore Ogouyemi-Hounto; Luc Salako Djogbenou
Journal:  Parasitol Res       Date:  2022-01-06       Impact factor: 2.289

2.  Tackling malaria transmission at a single cell level in an endemic setting in sub-Saharan Africa.

Authors:  Antoine Dara; Sunil Kumar Dogga; Jesse Rop; Dinkorma Ouologuem; Fatalmoudou Tandina; Arthur M Talman; Abdoulaye Djimdé; Mara K N Lawniczak
Journal:  Nat Commun       Date:  2022-05-13       Impact factor: 17.694

3.  Epidemiological and entomological studies of malaria transmission in Tibati, Adamawa region of Cameroon 6 years following the introduction of long-lasting insecticide nets.

Authors:  Lionel Brice Feufack-Donfack; Elangwe Milo Sarah-Matio; Luc Marcel Abate; Aline Gaelle Bouopda Tuedom; Albert Ngano Bayibéki; Christelle Maffo Ngou; Jean-Claude Toto; Maurice Marcel Sandeu; Carole Else Eboumbou Moukoko; Lawrence Ayong; Parfait Awono-Ambene; Isabelle Morlais; Sandrine Eveline Nsango
Journal:  Parasit Vectors       Date:  2021-05-08       Impact factor: 3.876

4.  Genetic polymorphism of merozoite surface protein-1 and merozoite surface protein-2 in Plasmodium falciparum isolates from Brazzaville, Republic of Congo.

Authors:  Pembe Issamou Mayengue; Mathieu Ndounga; Freddy Vladimir Malonga; Michel Bitemo; Francine Ntoumi
Journal:  Malar J       Date:  2011-09-22       Impact factor: 2.979

5.  Dynamics in multiplicity of Plasmodium falciparum infection among children with asymptomatic malaria in central Ghana.

Authors:  Akua Kyerewaa Botwe; Kwaku Poku Asante; George Adjei; Samuel Assafuah; David Dosoo; Seth Owusu-Agyei
Journal:  BMC Genet       Date:  2017-07-17       Impact factor: 2.797

6.  Plasmodium falciparum merozoite surface protein 1 block 2 gene polymorphism in field isolates along the slope of mount Cameroon: a cross - sectional study.

Authors:  Tobias O Apinjoh; Rolland B Tata; Judith K Anchang-Kimbi; Hanesh F Chi; Eleanor M Fon; Regina N Mugri; Delphine A Tangoh; Robert V Nyingchu; Stephen M Ghogomu; Theresa Nkuo-Akenji; Eric A Achidi
Journal:  BMC Infect Dis       Date:  2015-08-05       Impact factor: 3.090

7.  Molecular typing reveals substantial Plasmodium vivax infection in asymptomatic adults in a rural area of Cameroon.

Authors:  Jerome Fru-Cho; Violet V Bumah; Innocent Safeukui; Theresa Nkuo-Akenji; Vincent P K Titanji; Kasturi Haldar
Journal:  Malar J       Date:  2014-05-03       Impact factor: 2.979

8.  Sequence variation in Plasmodium falciparum merozoite surface protein-2 is associated with virulence causing severe and cerebral malaria.

Authors:  Suwanna Chaorattanakawee; Pornlada Nuchnoi; Hathairad Hananantachai; Uranan Tumkosit; David Saunders; Izumi Naka; Jun Ohashi; Jintana Patarapotikul
Journal:  PLoS One       Date:  2018-01-17       Impact factor: 3.240

9.  Genetically diverse Plasmodium falciparum infections, within-host competition and symptomatic malaria in humans.

Authors:  Paul Sondo; Karim Derra; Thierry Lefevre; Seydou Diallo-Nakanabo; Zekiba Tarnagda; Odile Zampa; Adama Kazienga; Innocent Valea; Hermann Sorgho; Jean-Bosco Ouedraogo; Tinga Robert Guiguemde; Halidou Tinto
Journal:  Sci Rep       Date:  2019-01-15       Impact factor: 4.379

10.  High genetic complexity but low relatedness in Plasmodium falciparum infections from Western Savannah Highlands and coastal equatorial Lowlands of Cameroon.

Authors:  Ngoh Ines Atuh; Damian Nota Anong; Fru-Cho Jerome; Eniyou Oriero; Nuredin Ibrahim Mohammed; Umberto D'Alessandro; Alfred Amambua-Ngwa
Journal:  Pathog Glob Health       Date:  2021-07-26       Impact factor: 3.735

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.